• 1. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 2. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 3. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 4. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 5. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755

Professional Introduction to exo-8-methyl-8-azabicyclo[3.2.1]octan-3-amine (CAS No. 81487-04-9)

exo-8-methyl-8-azabicyclo[3.2.1]octan-3-amine, a compound with the chemical identifier CAS No. 81487-04-9, represents a significant advancement in the field of medicinal chemistry and pharmacology. This bicyclic amine derivative has garnered considerable attention due to its unique structural framework and potential therapeutic applications. The compound’s molecular architecture, characterized by a fused bicyclic system incorporating an azabicyclo[3.2.1]octane core, positions it as a promising candidate for further exploration in drug discovery and development.

The structural complexity of exo-8-methyl-8-azabicyclo[3.2.1]octan-3-amine contributes to its distinctive chemical properties, which are of great interest to researchers seeking novel molecular entities with tailored biological activities. The presence of a nitrogen atom within the bicyclic framework introduces the possibility of diverse interactions with biological targets, making this compound a versatile scaffold for medicinal chemistry innovation.

Recent studies have highlighted the potential of azabicycloalkanes as privileged structures in drug design, owing to their ability to mimic natural product scaffolds and exhibit favorable pharmacokinetic profiles. The specific configuration of exo-8-methyl-8-azabicyclo[3.2.1]octan-3-amine, with its methyl-substituted bridgehead and tertiary amine functionality, suggests that it may interact with enzymes or receptors in ways that could lead to therapeutic benefits.

In the realm of pharmaceutical research, the synthesis and characterization of such complex molecules are critical steps toward understanding their biological relevance. Advances in synthetic methodologies have enabled the efficient preparation of intricate heterocyclic compounds like exo-8-methyl-8-azabicyclo[3.2.1]octan-3-amine, facilitating their integration into drug discovery programs.

The utility of this compound extends beyond its structural novelty; its potential applications in various therapeutic areas are being actively investigated. For instance, researchers are exploring its interactions with enzymes involved in metabolic pathways, as well as its binding affinity to specific receptors implicated in neurological disorders.

The development of high-throughput screening technologies has further accelerated the process of identifying bioactive molecules, including those derived from complex scaffolds like exo-8-methyl-8-azabicyclo[3.2.1]octan-3-amine. These technologies allow for rapid assessment of large libraries of compounds, enabling scientists to pinpoint promising candidates for further optimization.

The role of computational chemistry in predicting the biological activity of novel compounds cannot be overstated. Molecular modeling techniques have been instrumental in understanding how exo-8-methyl-8-azabicyclo[3.2.1]octan-3-amine might interact with biological targets at the molecular level, providing insights that guide experimental design and optimization efforts.

The synthesis of analogs and derivatives of this compound is an ongoing area of research, aimed at enhancing its pharmacological properties while maintaining its structural integrity. By modifying specific functional groups or introducing additional substituents, chemists can fine-tune the biological activity and selectivity of exo-8-methyl-8-azabicyclo[3.2.1]octan-3-amines.

The integration of interdisciplinary approaches, combining expertise from organic chemistry, biochemistry, and pharmacology, is essential for maximizing the therapeutic potential of compounds like this one. Collaborative efforts between academic institutions and pharmaceutical companies have been pivotal in advancing our understanding of how such molecules can be harnessed for medical applications.

The future prospects for research on exo-8-methyl-octanamines, including derivatives such as this one, appear promising given the growing interest in heterocyclic compounds as drug candidates. Continued investigation into their mechanisms of action and potential therapeutic benefits will likely yield valuable insights that contribute to the development of novel treatments for a range of diseases.

• 98998-25-5(8-Methyl-8-azabicyclo[3.2.1]octan-3-amine)
• 125541-18-6(8-Azabicyclo[3.2.1]octane,8-methyl-3-(1-piperidinyl)-)
• 67139-56-4(8-azabicyclo[3.2.1]octan-3-amine,8-methyl-n-propyl-exo-)
• 923944-33-6(3-(Piperidin-1-yl)-8-azabicyclo[3.2.1]octane)
• 87571-88-8(Endo-8-Methyl-8-azabicyclo[3.2.1]octan-3-amine)
• 832754-45-7(2-(2-Pyrrolidin-1-ylethyl)piperidine)
• 5004-07-9(4-(Pyrrolidinyl)piperidine)
• 67216-34-6(8-methyl-N-propyl-8-azabicyclo[3.2.1]octan-3-amine)
• 25082-00-2(2-(2-(Pyrrolidin-1-yl)ethyl)piperidine)
• 652144-66-6(Piperidine, 1-[2-[(2S)-1-methyl-2-pyrrolidinyl]ethyl]-)